ECI2
Basic information
Region (hg38): 6:4115693-4135597
Previous symbols: [ "PECI" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ECI2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 26 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 3 | 2 |
Variants in ECI2
This is a list of pathogenic ClinVar variants found in the ECI2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-4115909-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
6-4117312-G-T | not specified | Uncertain significance (Feb 13, 2024) | ||
6-4117360-A-G | not specified | Uncertain significance (Sep 25, 2023) | ||
6-4117373-G-A | Benign (Aug 15, 2017) | |||
6-4117414-G-T | not specified | Uncertain significance (May 29, 2024) | ||
6-4117442-T-C | not specified | Uncertain significance (May 26, 2024) | ||
6-4119187-T-G | not specified | Uncertain significance (Mar 24, 2023) | ||
6-4119205-T-C | not specified | Uncertain significance (Mar 28, 2024) | ||
6-4125260-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
6-4125267-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
6-4125299-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
6-4125353-A-G | not specified | Uncertain significance (Dec 13, 2023) | ||
6-4126146-G-A | Benign (Aug 15, 2017) | |||
6-4126148-C-T | not specified | Uncertain significance (May 04, 2022) | ||
6-4126184-G-T | not specified | Uncertain significance (Feb 05, 2024) | ||
6-4126192-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
6-4126229-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
6-4130383-T-C | not specified | Uncertain significance (Jun 01, 2022) | ||
6-4130425-T-C | not specified | Uncertain significance (Oct 12, 2021) | ||
6-4130464-T-C | not specified | Uncertain significance (Jan 20, 2023) | ||
6-4130541-T-C | not specified | Uncertain significance (Mar 20, 2023) | ||
6-4130542-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
6-4130796-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
6-4133559-A-G | not specified | Uncertain significance (Apr 06, 2022) | ||
6-4133563-C-T | not specified | Uncertain significance (Apr 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ECI2 | protein_coding | protein_coding | ENST00000380118 | 10 | 19909 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.55e-8 | 0.453 | 125621 | 0 | 127 | 125748 | 0.000505 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.00850 | 215 | 215 | 1.00 | 0.0000106 | 2586 |
Missense in Polyphen | 65 | 75.967 | 0.85564 | 880 | ||
Synonymous | 1.14 | 69 | 82.2 | 0.839 | 0.00000456 | 751 |
Loss of Function | 0.851 | 13 | 16.8 | 0.776 | 7.04e-7 | 223 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00116 | 0.00116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00196 | 0.00196 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000212 | 0.000211 |
Middle Eastern | 0.00196 | 0.00196 |
South Asian | 0.00115 | 0.00114 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species. Has a preference for 3-trans substrates (By similarity). {ECO:0000250}.;
- Pathway
- Peroxisome - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);fatty acid β-oxidation (unsaturated, odd number);Metabolism of lipids;Metabolism of proteins;Leukotriene metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;Omega-6 fatty acid metabolism;Di-unsaturated fatty acid beta-oxidation;fatty acid β-oxidation
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.0829
- hipred
- N
- hipred_score
- 0.187
- ghis
- 0.457
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.786
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Eci2
- Phenotype
Gene ontology
- Biological process
- protein targeting to peroxisome;fatty acid beta-oxidation using acyl-CoA oxidase
- Cellular component
- nucleoplasm;mitochondrion;peroxisome;peroxisomal matrix;cytosol;membrane;intracellular membrane-bounded organelle
- Molecular function
- fatty-acyl-CoA binding;dodecenoyl-CoA delta-isomerase activity;signaling receptor binding